Cargando…

Differences in the intrinsic chondrogenic potential of human mesenchymal stromal cells and iPSC‐derived multipotent cells

BACKGROUND: Human multipotent progenitor cells (hiMPCs) created from induced pluripotent stem cells (iPSCs) represent a new cell source for cartilage regeneration. In most studies, bone morphogenetic proteins (BMPs) are needed to enhance transforming growth factor‐β (TGFβ)‐induced hiMPC chondrogenes...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiang, Shiqi, Lin, Zixuan, Makarcyzk, Meagan J., Riewruja, Kanyakorn, Zhang, Yiqian, Zhang, Xiurui, Li, Zhong, Clark, Karen L., Li, Eileen, Liu, Silvia, Hao, Tingjun, Fritch, Madalyn R., Alexander, Peter G., Lin, Hang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763539/
https://www.ncbi.nlm.nih.gov/pubmed/36536500
http://dx.doi.org/10.1002/ctm2.1112
_version_ 1784853083375796224
author Xiang, Shiqi
Lin, Zixuan
Makarcyzk, Meagan J.
Riewruja, Kanyakorn
Zhang, Yiqian
Zhang, Xiurui
Li, Zhong
Clark, Karen L.
Li, Eileen
Liu, Silvia
Hao, Tingjun
Fritch, Madalyn R.
Alexander, Peter G.
Lin, Hang
author_facet Xiang, Shiqi
Lin, Zixuan
Makarcyzk, Meagan J.
Riewruja, Kanyakorn
Zhang, Yiqian
Zhang, Xiurui
Li, Zhong
Clark, Karen L.
Li, Eileen
Liu, Silvia
Hao, Tingjun
Fritch, Madalyn R.
Alexander, Peter G.
Lin, Hang
author_sort Xiang, Shiqi
collection PubMed
description BACKGROUND: Human multipotent progenitor cells (hiMPCs) created from induced pluripotent stem cells (iPSCs) represent a new cell source for cartilage regeneration. In most studies, bone morphogenetic proteins (BMPs) are needed to enhance transforming growth factor‐β (TGFβ)‐induced hiMPC chondrogenesis. In contrast, TGFβ alone is sufficient to result in robust chondrogenesis of human primary mesenchymal stromal cells (hMSCs). Currently, the mechanism underlying this difference between hiMPCs and hMSCs has not been fully understood. METHODS: In this study, we first tested different growth factors alone or in combination in stimulating hiMPC chondrogenesis, with a special focus on chondrocytic hypertrophy. The reparative capacity of hiMPCs‐derived cartilage was assessed in an osteochondral defect model created in rats. hMSCs isolated from bone marrow were included in all studies as the control. Lastly, a mechanistic study was conducted to understand why hiMPCs and hMSCs behave differently in responding to TGFβ. RESULTS: Chondrogenic medium supplemented with TGFβ3 and BMP6 led to robust in vitro cartilage formation from hiMPCs with minimal hypertrophy. Cartilage tissue generated from this new method was resistant to osteogenic transition upon subcutaneous implantation and resulted in a hyaline cartilage‐like regeneration in osteochondral defects in rats. Interestingly, TGFβ3 induced phosphorylation of both Smad2/3 and Smad1/5 in hMSCs, but only activated Smad2/3 in hiMPCs. Supplementing BMP6 activated Smad1/5 and significantly enhanced TGFβ’s compacity in inducing hiMPC chondrogenesis. The chondro‐promoting function of BMP6 was abolished by the treatment of a BMP pathway inhibitor. CONCLUSIONS: This study describes a robust method to generate chondrocytes from hiMPCs with low hypertrophy for hyaline cartilage repair, as well as elucidates the difference between hMSCs and hiMPCs in response to TGFβ. Our results also indicated the importance of activating both Smad2/3 and Smad1/5 in the initiation of chondrogenesis.
format Online
Article
Text
id pubmed-9763539
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-97635392022-12-20 Differences in the intrinsic chondrogenic potential of human mesenchymal stromal cells and iPSC‐derived multipotent cells Xiang, Shiqi Lin, Zixuan Makarcyzk, Meagan J. Riewruja, Kanyakorn Zhang, Yiqian Zhang, Xiurui Li, Zhong Clark, Karen L. Li, Eileen Liu, Silvia Hao, Tingjun Fritch, Madalyn R. Alexander, Peter G. Lin, Hang Clin Transl Med Research Articles BACKGROUND: Human multipotent progenitor cells (hiMPCs) created from induced pluripotent stem cells (iPSCs) represent a new cell source for cartilage regeneration. In most studies, bone morphogenetic proteins (BMPs) are needed to enhance transforming growth factor‐β (TGFβ)‐induced hiMPC chondrogenesis. In contrast, TGFβ alone is sufficient to result in robust chondrogenesis of human primary mesenchymal stromal cells (hMSCs). Currently, the mechanism underlying this difference between hiMPCs and hMSCs has not been fully understood. METHODS: In this study, we first tested different growth factors alone or in combination in stimulating hiMPC chondrogenesis, with a special focus on chondrocytic hypertrophy. The reparative capacity of hiMPCs‐derived cartilage was assessed in an osteochondral defect model created in rats. hMSCs isolated from bone marrow were included in all studies as the control. Lastly, a mechanistic study was conducted to understand why hiMPCs and hMSCs behave differently in responding to TGFβ. RESULTS: Chondrogenic medium supplemented with TGFβ3 and BMP6 led to robust in vitro cartilage formation from hiMPCs with minimal hypertrophy. Cartilage tissue generated from this new method was resistant to osteogenic transition upon subcutaneous implantation and resulted in a hyaline cartilage‐like regeneration in osteochondral defects in rats. Interestingly, TGFβ3 induced phosphorylation of both Smad2/3 and Smad1/5 in hMSCs, but only activated Smad2/3 in hiMPCs. Supplementing BMP6 activated Smad1/5 and significantly enhanced TGFβ’s compacity in inducing hiMPC chondrogenesis. The chondro‐promoting function of BMP6 was abolished by the treatment of a BMP pathway inhibitor. CONCLUSIONS: This study describes a robust method to generate chondrocytes from hiMPCs with low hypertrophy for hyaline cartilage repair, as well as elucidates the difference between hMSCs and hiMPCs in response to TGFβ. Our results also indicated the importance of activating both Smad2/3 and Smad1/5 in the initiation of chondrogenesis. John Wiley and Sons Inc. 2022-12-19 /pmc/articles/PMC9763539/ /pubmed/36536500 http://dx.doi.org/10.1002/ctm2.1112 Text en © 2022 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Xiang, Shiqi
Lin, Zixuan
Makarcyzk, Meagan J.
Riewruja, Kanyakorn
Zhang, Yiqian
Zhang, Xiurui
Li, Zhong
Clark, Karen L.
Li, Eileen
Liu, Silvia
Hao, Tingjun
Fritch, Madalyn R.
Alexander, Peter G.
Lin, Hang
Differences in the intrinsic chondrogenic potential of human mesenchymal stromal cells and iPSC‐derived multipotent cells
title Differences in the intrinsic chondrogenic potential of human mesenchymal stromal cells and iPSC‐derived multipotent cells
title_full Differences in the intrinsic chondrogenic potential of human mesenchymal stromal cells and iPSC‐derived multipotent cells
title_fullStr Differences in the intrinsic chondrogenic potential of human mesenchymal stromal cells and iPSC‐derived multipotent cells
title_full_unstemmed Differences in the intrinsic chondrogenic potential of human mesenchymal stromal cells and iPSC‐derived multipotent cells
title_short Differences in the intrinsic chondrogenic potential of human mesenchymal stromal cells and iPSC‐derived multipotent cells
title_sort differences in the intrinsic chondrogenic potential of human mesenchymal stromal cells and ipsc‐derived multipotent cells
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763539/
https://www.ncbi.nlm.nih.gov/pubmed/36536500
http://dx.doi.org/10.1002/ctm2.1112
work_keys_str_mv AT xiangshiqi differencesintheintrinsicchondrogenicpotentialofhumanmesenchymalstromalcellsandipscderivedmultipotentcells
AT linzixuan differencesintheintrinsicchondrogenicpotentialofhumanmesenchymalstromalcellsandipscderivedmultipotentcells
AT makarcyzkmeaganj differencesintheintrinsicchondrogenicpotentialofhumanmesenchymalstromalcellsandipscderivedmultipotentcells
AT riewrujakanyakorn differencesintheintrinsicchondrogenicpotentialofhumanmesenchymalstromalcellsandipscderivedmultipotentcells
AT zhangyiqian differencesintheintrinsicchondrogenicpotentialofhumanmesenchymalstromalcellsandipscderivedmultipotentcells
AT zhangxiurui differencesintheintrinsicchondrogenicpotentialofhumanmesenchymalstromalcellsandipscderivedmultipotentcells
AT lizhong differencesintheintrinsicchondrogenicpotentialofhumanmesenchymalstromalcellsandipscderivedmultipotentcells
AT clarkkarenl differencesintheintrinsicchondrogenicpotentialofhumanmesenchymalstromalcellsandipscderivedmultipotentcells
AT lieileen differencesintheintrinsicchondrogenicpotentialofhumanmesenchymalstromalcellsandipscderivedmultipotentcells
AT liusilvia differencesintheintrinsicchondrogenicpotentialofhumanmesenchymalstromalcellsandipscderivedmultipotentcells
AT haotingjun differencesintheintrinsicchondrogenicpotentialofhumanmesenchymalstromalcellsandipscderivedmultipotentcells
AT fritchmadalynr differencesintheintrinsicchondrogenicpotentialofhumanmesenchymalstromalcellsandipscderivedmultipotentcells
AT alexanderpeterg differencesintheintrinsicchondrogenicpotentialofhumanmesenchymalstromalcellsandipscderivedmultipotentcells
AT linhang differencesintheintrinsicchondrogenicpotentialofhumanmesenchymalstromalcellsandipscderivedmultipotentcells